One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Surgical Site Infection Control Market

[ 英語タイトル ] Surgical Site Infection Control Market - Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0082395
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - 3M
- Becton, Dickinson and Company
- Belimed AG
- bioMerieux SA
- Getinge Group
- Johnson & Johnson
- Kimberly-Clark Corporation
- Sotera Health
- Ansell Limited
- Steris Corporation
- Lac-Mac Limited
- Pacon Manufacturing Corp.
- American Polyfilm Inc.

[Report Description]

Currently, the global SSI control market is in the growing phase and is dominated by hospitals and developed regions, like North America. Increasing hospital-acquired infections and number of surgeries are increasingly driving the SSI control market across the world. Increased focus on preventing SSI through appropriate measures has further augmented the market in developed regions. Awareness about surgical site infections is also higher in the developed regions. This has led to higher adoption of SSI control products, thus, preventing infections among people. The increasing geriatric population has also impacted this market positively.

Key Market Trends

Superficial Incisional SSI Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Surgical site infection (SSI) represents the most common nosocomial infection and accounts for about 15% of all nosocomial infections. Surgical site infection is one of the most common complications of gastrointestinal surgery. This type of surgical procedures and wound closure methods affect the incidence of superficial incisional surgical site infection. There is an increase in the incidence of superficial incisional SSI infections, as compared to deep incisional SSI and organ or space SSIs.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the surgical site infection control market, with the United States contributing the largest share in the regional revenue. SSIs are considered the most common (tied with pneumonia) healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States. SSIs occur in an estimated 2-5% of patients undergoing inpatient surgery. The estimated annual incidence of SSIs in the United States ranges from 160,000 to 300,000, and the estimated annual cost ranges from USD 3.5 billion to USD 10 billion. Hence, the rising need for the prevention of SSI can be attributed to the rising number of surgical procedures performed in the United States.

Competitive Landscape

3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Grou,p and Johnson & Johnson are some of the major players in the surgical site infection control market The competitive rivalry of the market studied has intensified, owing to the constant product innovations across the world.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Hospital Acquired Infection
4.2.2 Regulatory Guidelines for Hospital Infection Prevention and Control
4.2.3 Increasing Number of Surgeries
4.2.4 Rapidly Growing Geriatric Population
4.3 Market Restraints
4.3.1 Lack of Awareness of Hospital Infection Prevention and Control
4.3.2 Increased Use of Outpatient Treatment
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Manual Reprocessors Solution
5.1.2 Disinfectants Hand Disinfectants Skin Disinfectants
5.1.3 Surgical Scrubs
5.1.4 Hair Clippers
5.1.5 Surgical Drapes
5.1.6 Surgical Irrigation
5.1.7 Skin Preparation Solution
5.1.8 Medical Nonwovens
5.1.9 Surgical Gloves
5.1.10 Other Products
5.2 By Surgery/Procedure
5.2.1 Cataract Surgery
5.2.2 Cesarean Section
5.2.3 Dental Restoration
5.2.4 Gastric Bypass
5.2.5 Other Surgeries/Procedures
5.3 By Type of Infection
5.3.1 Superficial Incisional SSI
5.3.2 Deep Incisional SSI
5.3.3 Organ or Space SSI
5.4 By End User
5.4.1 Hospitals
5.4.2 Ambulatory Surgical Centers
5.5 Geography
5.5.1 North America United States Canada Mexico
5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.5.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 3M
6.1.2 Becton, Dickinson and Company
6.1.3 Belimed AG
6.1.4 bioMerieux SA
6.1.5 Getinge Group
6.1.6 Johnson & Johnson
6.1.7 Kimberly-Clark Corporation
6.1.8 Sotera Health
6.1.9 Ansell Limited
6.1.10 Steris Corporation
6.1.11 Lac-Mac Limited
6.1.12 Pacon Manufacturing Corp.
6.1.13 American Polyfilm Inc.




Recommended reports